There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...
BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
BACKGROUND: Oscillatory shear stress (OSS), resulting from disturbed blood flow, is implicated in atherosclerotic plaque formation by incompletely understood mechanisms. This study aims to elucidate ...
A 68-year-old man without previous comorbidities presented to the emergency department with complaints of palpitations and giddiness. On examination, his pulse rate was 92 beats per minute, and his ...
Background: Middle-aged and older endurance athletes have increased prevalence of coronary artery disease (CAD) on coronary CT angiography (CCTA) compared to healthy controls, despite similarly low ...
We conducted a prospective open-label study during the 30-day run-in period of the LoDoCo2 trial (Low-Dose Colchicine 2; URL: https://www.anzctr.org.au/; identifier ...
Arteriosclerosis, Thrombosis, and Vascular Biology Circulation Circulation Research Hypertension Stroke Journal of the American Heart Association Circulation: Arrhythmia and Electrophysiology ...
A 40-year-old woman with history of hypothyroidism and tubal ligation presented with left lower-extremity pain and swelling. Duplex ultrasonography revealed extensive, occlusive deep vein thrombosis ...
Background: Hypertension is the leading preventable risk factor for premature death and disability worldwide. Aims: We estimated global disparities in hypertension prevalence, awareness, treatment, ...
The Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) 1 amplifies the controversy over calcium antagonists and increased cancer risk. 2 In this 36-month, ...
Background: Cardiac allograft vasculopathy (CAV) is an important cause of mortality after heart transplantation (HT). Dyslipidemia is a major contributor to the development of CAV. The safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results